Raffaele Palmirotta received his MD degree in 1991 at the University of Chieti, Italy. Specialized in Clinical Pathology (summa cum laude) in 1996 and in Medical Genetic in 2006 at the University of Chieti, Italy. In 2001 Ph.D. in "Molecular diagnostic techniques for the study of hereditary cancer and gene therapy" at the University of Chieti, Italy. In 2012 he completed a Master in “Forensic Genetic”, University of Rome “Tor Vergata” and in 2016 a Master in “Cytogenetic” University of Rome “Roma 3”, Italy. From 1991 to 2001 she joined the Department of Oncology and Neurosciences at the University of Chieti as MD Degree. From 2001 to 2002 Researcher at the IRCCS Istituto Regina Elena per lo Studio e la Cura dei Tumori, Rome. From 2001 to 2005 Deputy Chief at the Laboratory of Clinical Pathology, IRCCS Istituto Regina Elena per lo Studio e la Cura dei Tumori, Rome. From 2005 to 2013 he joined the IRCCS San Raffaele Pisana, Rome, as Responsible of Molecular Diagnosis Section of “Department of Laboratory Medicine and Advanced Biotechnologies”. From 2014 to 2015full Professor at the San Raffaele Roma Open University, Rome, From 2015 to date collaborator at Oncogenomic Research Center “Department of Internal Medicine and Clinical Oncology”, University of Bari “Aldo Moro”, Italy. From 2001-to 2006 Contract Professor of "Heredity and cancer" Residency School of Oncology, "Tor Vergata" University, Rome. 2007-Present Professor of "Medical Genetic" Technician School, School of Medicine, University of Rome La Sapienza. His major scientific interest is focused on translational research involving: - new diagnostic approaches for cancer diagnosis: from the detection of serum tumor markers and the biomolecular detection tumor cells in blood and bone marrow to proteomics; - molecular evaluation of genes involved in metabolic syndrome (i.e., IRS1, IRS2, OB etc.); -t ranslational research in Oncology: evaluation of the clinical usefulness of new diagnostic and/or prognostic parameters in Clinical Oncology; - molecular evaluation of genes involved in gastrointestinal and breast inherited cancer (i.e., hMLH1, hMSH2, APC, BRCA1, BRAC2, etc.); - molecular evaluation of genomic instability of human cancer, and novel mechanisms of cancer progression; - pharmacogenomic and pharmacogenetic of anticancer, cardiovascular and neurological drugs; - association from human patology and genomic sequence variants (SNPs); - Identification of biological identity using genetic forensic tool - Biobanking and biobanking applied sciences Biobanking. Active participation in the creation and maintenance of a Biological Bank Multidisciplinary Interisituzionale, with particular interest in the design, definition, structuring and publication of dedicated Standard Operating Procedures (SOPs) aimed at the cryopreservation of biological samples useful for the extraction of nucleic acids. Dr Palmirotta has been and is the principal investigator and/or coordinator of numerous studies granted by governmental and scientific organizations, member of several national and international scientific societies, reviewer of several Peer-Reviewed Scientific Journals. Dr. Palmirotta is author of 106 papers published in international journals for a total Impact Factor of more than 300 (H Index 22), more than 10 book chapters and more than 200 abstracts presented at national and international meetings.